GPCRStructure Therapeutics Inc. American Depositary Shares

49.09USD-9.31%Mkt Cap: 3.50B $P/E:

Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States…

Key Statistics

Company
Market Cap3.50B $
Enterprise Value2.27B $
Revenue (TTM)
Gross Profit
Net Income (TTM)-141.20M $
Revenue/Share
Last Price49.09 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees281
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-23.89
PEG
EV/EBITDA-8.53
EV/Revenue
P/S
P/B2.36
EPS (TTM)-2.84
EPS (Forward)-2.11
52W Range
18.2640% of range94.90
52W High94.90 USD
52W Low18.26 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-9.31%
ROA-8.91%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-222.20M $
CapEx (TTM)3.61M $
FCF Margin
FCF Yield-3.40%
Net Debt-1.34B $
Net Debt/EBITDA5.03
Balance Sheet
Debt/Equity0.00
Current Ratio20.75
Quick Ratio20.31
Book Value/Sh21.41 USD
Cash/Share18.83 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)104.77 USD
Upside (mean)+113.4%
Target Range69.50 USD145.00 USD
$69.50+113.4% to mean$145.00
# Analysts15
Ownership
Shares Out.71.31M
Float54.64M
Insiders2.85%
Institutions97.08%
Short Interest
Short Ratio9.4d
Short % Float11.67%
Short % Out.8.51%
Shares Short6.05M
Short (prev mo.)6.13M
Technical
SMA 5049.92 (-1.7%)
SMA 20053.62 (-8.4%)
Beta-1.51
S&P 52W Chg18.16%
Avg Vol (30d)525.54K
Avg Vol (10d)680.09K
Technical Indicators
RSI (14)44.5
MACD1.1097
MACD Signal1.2140
MACD Hist.-0.1043
BB Upper56.19 USD
BB Middle51.08 USD
BB Lower45.98 USD
BB Width19.99%
ATR (14)2.665 USD
Vol Ratio (20d)1.17x